A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation—and pointing ...

At ESAD 2025, researchers reported that Viperin (RSAD2) is strongly induced by inflammatory cytokines in pancreatic beta cells and islets.

Medically reviewed by Violetta Shamilova, PharmD Key Takeaways Poor sleep can not only make you feel lousy, but it can also lead to chronic conditions. Implementing healthy habits and relaxation ...

Discover investment opportunities in Rezolute, Inc. as new drug ersodetug advances in phase 3 HI trials, with catalysts ...

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective ...

On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

The open-angle glaucoma market is projected to grow steadily, driven by the rising global prevalence of glaucoma due to aging populations and increasing awareness of early diagnosis. Additionally, the ...

Long-term benzodiazepine use in older adults disrupts sleep patterns, leading to lighter sleep and potential cognitive ...

Bicara Therapeutics Inc.’s ficera shows strong results in HPV-negative HNSCC trials. But is BCAX stock worth buying now? Click for more on this biotech's prospects.

The new Prescription Drug User Fee Act target date is now December 7, 2025. The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for ...

Beta-blockers may fight the progression of triple-negative breast cancer, researchers have found Getty Beta blockers — a commonly prescribed blood pressure medication — may be useful in stopping the ...